Tripelennamine Hydrochloride

CHEMBL1200446 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
291.8 g/mol
LogP
Phase
4

Tripelennamine hydrochloride is the hydrochloride salt of tripelennamine, an ethylenediamine-class H1 antihistamine used to relieve symptoms of allergic rhinitis, urticaria, and other hypersensitivity reactions. It acts by competitively inhibiting histamine at H1 receptors, and its sedative properties result from central H1 blockade. The hydrochloride salt form is used in oral tablet and liquid formulations.

分子量

291.8200 g/mol

TPSA

19.40 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCN(Cc1ccccc1)c1ccccn1.Cl

InChI

InChI=1S/C16H21N3.ClH/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15;/h3-11H,12-14H2,1-2H3;1H

Molecular Formula

C16H22ClN3

HBD / HBA

1 / 3

回転可能結合数

6

重原子数

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Tripelennamine hydrochloride is the hydrochloride salt of tripelennamine, an ethylenediamine-class H1 antihistamine used to relieve symptoms of allergic rhinitis, urticaria, and other hypersensitivity reactions. It acts by competitively inhibiting histamine at H1 receptors, and its sedative properties result from central H1 blockade. The hydrochloride salt form is used in oral tablet and liquid formulations.

Yes, Tripelennamine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200446. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9066. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.